{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:40:19Z","timestamp":1792712419895,"version":"4.5.0"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T00:00:00Z","timestamp":1314748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023841","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T07:20:06Z","timestamp":1314861606000},"page":"e23841","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["High-Content Chemical and RNAi Screens for Suppressors of Neurotoxicity in a Huntington's Disease Model"],"prefix":"10.1371","volume":"6","author":[{"given":"Joost","family":"Schulte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine J.","family":"Sepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Troy","family":"Littleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.str.2009.08.002","article-title":"Secondary structure of Huntingtin amino-terminal region.","volume":"17","author":"MW Kim","year":"2009","journal-title":"Structure"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/exnr.1998.6919","article-title":"Regional specificity of brain atrophy in Huntington&apos;s disease.","volume":"154","author":"GM Halliday","year":"1998","journal-title":"Exp Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.nbd.2010.07.014","article-title":"Cerebral cortex structure in prodromal Huntington disease.","volume":"40","author":"PC Nopoulos","year":"2010","journal-title":"Neurobiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.","volume":"46","author":"X Gu","year":"2005","journal-title":"Neuron"},{"key":"ref5","first-page":"201","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease.","volume":"82","author":"JS Paulsen","year":"2010","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","article-title":"Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington&apos;s disease.","volume":"2","author":"X Gu","year":"2007","journal-title":"Mol Neurodegener"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.","volume":"171","author":"JY Shin","year":"2005","journal-title":"J Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","article-title":"Pathophysiology of Huntington&apos;s disease: from huntingtin functions to potential treatments.","volume":"21","author":"E Roze","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington&apos;s disease age of onset.","volume":"101","author":"NS Wexler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/gepi.20317","article-title":"Genomewide linkage scan reveals novel loci modifying age of onset of Huntington&apos;s disease in the Venezuelan HD kindreds.","volume":"32","author":"J Gayan","year":"2008","journal-title":"Genet Epidemiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1242\/dmm.000653","article-title":"Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington&apos;s disease model.","volume":"2","author":"S Zhang","year":"2009","journal-title":"Dis Model Mech"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington&apos;s disease.","volume":"20","author":"SH Li","year":"2004","journal-title":"Trends Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/hmg\/8.9.1807","article-title":"A putative Drosophila homolog of the Huntington&apos;s disease gene.","volume":"8","author":"Z Li","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e7275","DOI":"10.1371\/journal.pone.0007275","article-title":"RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation.","volume":"4","author":"J Doumanis","year":"2009","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1534\/genetics.109.112516","article-title":"A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila.","volume":"184","author":"S Zhang","year":"2010","journal-title":"Genetics"},{"key":"ref16","first-page":"3058","article-title":"Towards the treatment of polyglutamine diseases: the modulatory role of protein context.","volume":"17","author":"AL Robertson","year":"2010","journal-title":"Curr"},{"key":"ref17","first-page":"3224","article-title":"Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington&apos;s disease.","author":"W-CM Lee","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.","author":"R Graham","year":"2006","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.","volume":"118","author":"AH Brand","year":"1993","journal-title":"Development"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington&apos;s disease: a clinical review.","volume":"5","author":"RA Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1000111","DOI":"10.1371\/journal.pgen.1000111","article-title":"Identification of neural outgrowth genes using genome-wide RNAi.","volume":"4","author":"KJ Sepp","year":"2008","journal-title":"PLoS Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12021-010-9067-9","article-title":"Automatic robust neurite detection and morphological analysis of neuronal cell cultures in high-content screening.","volume":"8","author":"C Wu","year":"2010","journal-title":"Neuroinformatics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-6-1","article-title":"Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.","volume":"6","author":"J Wang","year":"2005","journal-title":"BMC Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.","author":"B Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","article-title":"Progressive decrease in chaperone protein levels in a mouse model of Huntington&apos;s disease and induction of stress proteins as a therapeutic approach.","volume":"13","author":"DG Hay","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","article-title":"A potent small molecule inhibits polyglutamine aggregation in Huntington&apos;s disease neurons and suppresses neurodegeneration in vivo.","volume":"102","author":"X Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2004.02530.x","article-title":"The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism.","volume":"90","author":"PC Chin","year":"2004","journal-title":"J Neurochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease.","volume":"37","author":"K Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling.","volume":"6","author":"RJ Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"19287","DOI":"10.1016\/S0021-9258(17)30656-7","article-title":"Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site.","author":"R Hertzberg","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.","author":"R Shaw","year":"2005","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1053\/j.gastro.2006.07.032","article-title":"Neither LKB1 nor AMPK are the direct targets of metformin.","author":"D Hardie","year":"2006","journal-title":"Gastroenterology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/jf802864k","article-title":"Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in PC12 cells via modulation of the PI3K\/Akt pathway.","volume":"57","author":"TC Kao","year":"2009","journal-title":"J Agric Food Chem"},{"key":"ref35","first-page":"21","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing.","volume":"12","author":"R Zoncu","year":"2010","journal-title":"Nat"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.","volume":"43","author":"JD Morrisett","year":"2002","journal-title":"J Lipid Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo.","volume":"2","author":"E Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00002018-200528020-00006","article-title":"Benefit-risk assessment of sirolimus in renal transplantation.","volume":"28","author":"DR Kuypers","year":"2005","journal-title":"Drug Saf"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000118413.92211.B6","article-title":"Sirolimus-associated pulmonary toxicity.","volume":"77","author":"PT Pham","year":"2004","journal-title":"Transplantation"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1200\/JCO.2010.29.2235","article-title":"Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.","volume":"29","author":"JP Maroto","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature01296","article-title":"A role for Drosophila LKB1 in anterior\u2013posterior axis formation and epithelial polarity.","author":"S Martin","year":"2003","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ng0198-38","article-title":"Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.","volume":"18","author":"DE Jenne","year":"1998","journal-title":"Nat Genet"},{"key":"ref43","author":"W van Veelen","year":"2011"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.cdd.4401790","article-title":"JNK pathway mediates apoptotic cell death induced by tumor suppressor LKB1 in Drosophila.","volume":"13","author":"JH Lee","year":"2006","journal-title":"Cell Death Differ"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","article-title":"Small molecules enhance autophagy and reduce toxicity in Huntington&apos;s disease models.","volume":"3","author":"S Sarkar","year":"2007","journal-title":"Nat Chem Biol"},{"key":"ref46","first-page":"9","article-title":"Chemical modulators of autophagy as biological probes and potential therapeutics.","volume":"7","author":"A Fleming","year":"2011","journal-title":"Nat"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway.","author":"A Yamamoto","year":"2006","journal-title":"Journal of Cell Biology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1000450","DOI":"10.1371\/journal.pbio.1000450","article-title":"Widespread protein aggregation as an inherent part of aging in C. elegans.","volume":"8","author":"DC David","year":"2010","journal-title":"PLoS"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.201105010","article-title":"Nuclear translocation of AMPK-{alpha}1 potentiates striatal neurodegeneration in Huntington&apos;s disease.","volume":"194","author":"TC Ju","year":"2011","journal-title":"J Cell Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pnpbp.2008.12.014","article-title":"Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies.","volume":"33","author":"GR Juszczak","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e4262","DOI":"10.1371\/journal.pone.0004262","article-title":"Glial cell lineage expression of mutant ataxin-1 and huntingtin induces developmental and late-onset neuronal pathologies in Drosophila models.","volume":"4","author":"T Tamura","year":"2009","journal-title":"PLoS One"},{"key":"ref52","first-page":"10653","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.","volume":"285","author":"J Bradford","year":"2010","journal-title":"J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/glia.20098","article-title":"Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila.","volume":"49","author":"D Kretzschmar","year":"2005","journal-title":"Glia"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain.","volume":"60","author":"E Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/2210","article-title":"Gap-junction-mediated propagation and amplification of cell injury.","volume":"1","author":"JH Lin","year":"1998","journal-title":"Nat Neurosci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e21108","DOI":"10.1371\/journal.pone.0021108","article-title":"Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer&apos;s disease.","volume":"6","author":"H Takeuchi","year":"2011","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.","volume":"104","author":"M DiFiglia","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.1523\/JNEUROSCI.23-35-11015.2003","article-title":"Mechanisms of caspase-independent neuronal death: energy depletion and free radical generation.","volume":"23","author":"IC Lang-Rollin","year":"2003","journal-title":"J Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/sj.onc.1207936","article-title":"Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.","volume":"23","author":"J Kluza","year":"2004","journal-title":"Oncogene"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/excr.1995.1376","article-title":"Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy.","volume":"221","author":"S Reipert","year":"1995","journal-title":"Exp Cell Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e2009","DOI":"10.1371\/journal.pone.0002009","article-title":"Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation.","volume":"3","author":"X Fu","year":"2008","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bmc.2003.11.036","article-title":"Camptothecin: current perspectives.","volume":"12","author":"CJ Thomas","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005072-199902000-00006","article-title":"Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.","volume":"58","author":"E Sapp","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","article-title":"Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.","volume":"40","author":"S Gunawardena","year":"2003","journal-title":"Neuron"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.","volume":"24","author":"E Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.","volume":"431","author":"M Arrasate","year":"2004","journal-title":"Nature"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2010.05.026","article-title":"Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.","volume":"40","author":"SS Ambegaokar","year":"2010","journal-title":"Neurobiol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1517\/17460440903527675","article-title":"Non-mammalian animal models of Parkinson&apos;s disease for drug discovery.","volume":"5","author":"KL Lim","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"ref69","author":"CJ O'Kane","year":"2011"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.genet.39.110304.095804","article-title":"Drosophila as a model for human neurodegenerative disease.","volume":"39","author":"J Bilen","year":"2005","journal-title":"Annu Rev Genet"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","article-title":"Identification of combinatorial drug regimens for treatment of Huntington&apos;s disease using Drosophila.","volume":"102","author":"N Agrawal","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1102-1185","article-title":"Pharmacological prevention of Parkinson disease in Drosophila.","author":"PK Auluck","year":"2002","journal-title":"Nat Med"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1126\/science.284.5422.1985","article-title":"Preventing neurodegeneration in the Drosophila mutant bubblegum.","volume":"284","author":"KT Min","year":"1999","journal-title":"Science"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2010.05.020","article-title":"Drosophila neuroligin 1 promotes growth and postsynaptic differentiation at glutamatergic neuromuscular junctions.","volume":"66","author":"D Banovic","year":"2010","journal-title":"Neuron"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrn2029","article-title":"Development: Neuroligin knockouts: form but no function.","volume":"7","author":"R Williams","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1523\/JNEUROSCI.5823-09.2010","article-title":"DMob4\/Phocein regulates synapse formation, axonal transport, and microtubule organization.","volume":"30","author":"J Schulte","year":"2010","journal-title":"J Neurosci"},{"key":"ref78","article-title":"Statistical Methods for Research Workers;","author":"RA Fisher","year":"1932"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T18:32:51Z","timestamp":1638469971000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023841"}},"subtitle":[],"editor":[{"given":"Mark R.","family":"Cookson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,31]]},"references-count":78,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023841","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,31]]}}}